HomeGeneticsGeneDKC1 gene
Back to Gene
DKC1 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

DKC1 gene

The DKC1 gene provides instructions for the protein dyskerin, which is vital for maintaining telomeres and producing ribosomal RNA.

Normal Function

The DKC1 gene provides instructions for making a protein called dyskerin. This protein is involved in maintaining structures called telomeres, which are found at the ends of chromosomes. Telomeres help protect chromosomes from abnormally sticking together or breaking down (degrading).

In most cells, telomeres become progressively shorter as the cell divides. After a certain number of cell divisions, the telomeres become so short that they trigger the cell to stop dividing or to self-destruct (undergo apoptosis).

Telomeres are maintained by two important protein complexes, telomerase and shelterin. Telomerase counteracts the shortening of telomeres by adding small repeated segments of DNA to the ends of chromosomes each time the cell divides. One component of telomerase, called hTR, provides a template for creating the repeated sequence of DNA that telomerase adds to the ends of chromosomes. The dyskerin protein attaches (binds) to hTR and helps stabilize the telomerase complex.

In most types of cells, telomerase is either undetectable or active at very low levels. However, telomerase is highly active in cells that divide rapidly, such as cells that line the lungs and gastrointestinal tract, cells in bone marrow, and cells of the developing fetus. Telomerase allows these cells to divide many times without becoming damaged or undergoing apoptosis. Telomerase is also abnormally active in most cancer cells, which grow and divide without control or order.

Dyskerin is also involved in the production of ribosomal RNA (rRNA), a chemical cousin of DNA. Ribosomal RNA is required for assembling protein building blocks (amino acids) into functioning proteins.

Health Conditions Related to Genetic Changes

Dyskeratosis congenita

More than 40 mutations in the DKC1 gene have been identified in people with dyskeratosis congenita. This disorder is characterized by changes in skin coloring (pigmentation), white patches inside the mouth (oral leukoplakia), and abnormally formed fingernails and toenails (nail dystrophy). People with dyskeratosis congenita have an increased risk of developing several life-threatening conditions, including cancer and a progressive lung disease called pulmonary fibrosis. Many affected individuals also develop a serious condition called aplastic anemia, also known as bone marrow failure, which occurs when the bone marrow does not produce enough new blood cells.

Most of the DKC1 gene mutations that cause dyskeratosis congenita change single amino acids in the dyskerin protein. Researchers believe that these changes probably interfere with the dyskerin protein's ability to bind to hTR, resulting in dysfunction of the telomerase complex.

Impaired telomerase function prevents the normal maintenance of telomeres and leads to reduced telomere length. Cells that divide rapidly are especially vulnerable to the effects of shortened telomeres. As a result, people with dyskeratosis congenita may experience a variety of problems affecting quickly dividing cells in the body, such as cells of the nail beds, hair follicles, skin, lining of the mouth (oral mucosa), and bone marrow.

Breakage and instability of chromosomes resulting from inadequate telomere maintenance may lead to genetic changes that allow cells to divide in an uncontrolled way, resulting in the development of cancer in some people with dyskeratosis congenita.

Idiopathic pulmonary fibrosis

MedlinePlus Genetics provides information about Idiopathic pulmonary fibrosis.

Other Names for This Gene

  • CBF5
  • CBF5 homolog
  • cbf5p homolog
  • DKC
  • DKC1_HUMAN
  • dyskeratosis congenita 1, dyskerin
  • dyskerin
  • FLJ97620
  • H/ACA ribonucleoprotein complex subunit 4
  • H/ACA ribonucleoprotein complex subunit 4 isoform 1
  • H/ACA ribonucleoprotein complex subunit 4 isoform 2
  • NAP57
  • NOLA4
  • nopp140-associated protein of 57 kDa
  • nucleolar protein family A member 4
  • nucleolar protein NAP57
  • snoRNP protein DKC1
  • XAP101

Frequently Asked Questions

DKC1 mutations typically lead to dyskeratosis congenita or related telomere biology disorders. Common early signs include abnormal skin pigmentation (often in a reticular or lacy pattern), nail dystrophy (thickening, brittleness, or loss of nails), and oral leukoplakia (white patches in the mouth). As the condition progresses, bone marrow failure can occur, leading to anemia, frequent infections, or bleeding due to low blood cell counts. Pulmonary fibrosis (scarring of the lungs) is another serious complication that may cause shortness of breath. These symptoms distinguish it from other genetic disorders because they affect multiple tissues involved in rapid cell turnover, such as the skin, nails, and bone marrow, rather than a single organ system.
Diagnosis usually begins with a clinical evaluation of characteristic symptoms like nail changes and skin pigmentation. A complete blood count (CBC) is essential to check for cytopenias (low blood cell counts), which may indicate bone marrow failure. Telomere length measurement via flow cytometry is a key diagnostic tool; individuals with DKC1 mutations often have abnormally short telomeres for their age. Definitive diagnosis is confirmed through genetic testing, specifically sequencing the DKC1 gene to identify pathogenic variants. In some cases, if the genetic test is negative but clinical suspicion remains high, further testing for other telomere-related genes or functional assays may be considered.
The most serious long-term complication of DKC1-related disorders is bone marrow failure, which can progress to aplastic anemia. Management often involves supportive care such as blood transfusions and growth factors to stimulate blood cell production. In severe cases, a hematopoietic stem cell transplant (HSCT) may be necessary to replace the failing bone marrow. However, HSCT in telomere biology disorders carries specific risks, including graft-versus-host disease and liver toxicity, so it is typically reserved for patients with severe bone marrow failure or those who have developed myelodysplastic syndrome. Regular monitoring of blood counts and lung function is critical to detect and manage these complications early.
DKC1-related disorders are typically inherited in an autosomal dominant pattern. This means that if one parent has the mutation, each child has a 50 percent chance of inheriting it. However, the condition can also result from a new (de novo) mutation in the affected individual, with no family history. If a parent is diagnosed, genetic counseling is recommended to discuss the risks for future children. Prenatal or preimplantation genetic testing is available for families who wish to know the status of a fetus or embryo. It is important to note that the severity of symptoms can vary widely, even among family members with the same mutation, a phenomenon known as variable expressivity.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss